DOLSMUR: Pain Management in Primary Intervention of the Mobile Emergency and Resuscitation Service

Sponsor
Centre Hospitalier René Dubos (Other)
Overall Status
Recruiting
CT.gov ID
NCT05791253
Collaborator
(none)
439
1
23
581

Study Details

Study Description

Brief Summary

The aim of the study is to carry out an inventory of practices relating to the management of pain: its recognition, assessment and treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Pain management

Detailed Description

Pain is one of the most frequent reasons for seeking emergency care, with a prevalence of approximately 42% in pre-hospital care.

Pain management practices are defined by the French Society of Anaesthesia and Intensive Care (SFAR) and the French Society of Emergency Medicine (SFMU).

Pain must be systematically managed and treated. To do this, it is necessary to start by assessing the pain using self-assessment scales, the VAS (Visual Analogue Pain Scale) or the EN (Numerical Pain Scale) being the two validated scales.

Depending on the intensity of the pain, appropriate treatments should be prescribed:
  • If EN < 6: level I or II analgesic

  • If EN > 6: morphine titration Finally, after the treatment has been implemented, the pain must be re-evaluated using the same self-assessment scales in order to attest to the effectiveness of the treatment.

There is a lack of knowledge of the recommendations for pain management and assessment: 49% of SMUR doctors do not know the SFAR recommendations and only 17% define severe acute pain by a VAS or ENS greater than 6/10.

The aim of the study is to carry out an inventory of practices relating to the management of pain: its recognition, assessment and treatment and to check whether pain management was carried out according to the recommendations of the French Society of Anaesthesia and Intensive Care (SFAR) and the French Society of Emergency Medicine (SFMU).

Study Design

Study Type:
Observational
Anticipated Enrollment :
439 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Pain Management in Adults in Primary Intervention of the Mobile Emergency and Resuscitation Service of Pontoise
Actual Study Start Date :
Mar 9, 2023
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Evaluation of pain management according to the recommendations of the SFAR and SFMU [At the end of the study, an average of one month]

    The the recommendations of the SFAR and SFMU about Pain management is based on a composite criterion with the following items: Pain recognition and assessment EN (Numerical scale) Implementation of an adapted therapy (prescriptions) according to the pain scale scores Re-evaluation of pain EN (Numerical scale) The evaluation of the objective is based on this composite criterion : for each item, the answer will be Yes or No. The outcom is validate if the answer of each item is yes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria :
  • Patients over 18 years of age,

  • Patient managed on primary intervention file between 01/11 and 30/11/2021, between 01/03 and 31/03/2022 or between 01/08 and 31/08/2022,

  • Patient transferred to NOVO hospital (Pontoise, Beaumont-sur-Oise or Magny en Vexin site) for further medical care.

Exclusion Criteria :
  • Patient in Cardiorespiratory Arrest (CRA),

  • Patient in coma,

  • Patient without applicant,

  • Patient who has expressed his opposition to the collect of his data.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mobile Emergency and Resuscitation Unit - NOVO Hospital - Pontoise Site Pontoise France 95300

Sponsors and Collaborators

  • Centre Hospitalier René Dubos

Investigators

  • Principal Investigator: Olivier Fancelli, Hospital NOVO - Pontoise site

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Hospitalier René Dubos
ClinicalTrials.gov Identifier:
NCT05791253
Other Study ID Numbers:
  • CHRD 1322
First Posted:
Mar 30, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier René Dubos
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 30, 2023